Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aspire Biopharma Holdings, Inc. (ASBP) vs Phio Pharmaceuticals Corp. (PHIO)

Aspire Biopharma Holdings, Inc. and Phio Pharmaceuticals Corp. are both Biotechnology companies. Aspire Biopharma Holdings, Inc. and Phio Pharmaceuticals Corp. are of similar size ($12.4M and $12.2M). Phio Pharmaceuticals Corp. has negative trailing earnings, so its P/E is not meaningful; Aspire Biopharma Holdings, Inc. trades at 0.2×. Phio Pharmaceuticals Corp. has the higher net margin (0.00% vs −11,309.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Phio Pharmaceuticals Corp. leads on 10 and Aspire Biopharma Holdings, Inc. on 4.

Valuation

Metric ASBP PHIO Biotechnology median
P/E 0.23 n/m 7.88
P/S 88.39 86.27 11.47
P/B 0.73 0.93 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.09 0.74
EV/Sales (7.59) (9.03) 10.73
Earnings yield 436.88% (127.72%) (28.84%)
Free cash flow yield (83.22%) (104.03%) (23.03%)

Profitability

Metric ASBP PHIO Biotechnology median
Gross margin (24.97%) 0.00% 65.16%
Operating margin (7,491.61%) 0.00% 0.00%
Net margin (11,309.31%) 0.00% 0.00%
Free cash flow margin (7,355.07%) 0.00% 0.00%
Return on equity (1,032.15%) (113.71%) (57.72%)
Return on assets (152.09%) (100.78%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASBP PHIO Biotechnology median
Revenue growth (TTM) — 78.95% 5.64%
EPS growth (last fiscal year) (762.74%) 84.03% —
Revenue growth, 5-year CAGR — (21.62%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ASBP PHIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 8.39 4.73
Net debt to EBITDA (0.16) 2.28 0.96

Dividend

Metric ASBP PHIO Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ASBP PHIO Biotechnology median
Market cap 12.20m 12.43m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack